May 12, 2026BoardMeeting
BoardMental Health Medication Advisory Committee Meeting Minutes Open Session
The committee discussed and approved updates to medication criteria, including the addition of Arynta for ADHD and changes to step therapy for several antipsychotic medications such as Caplyta, Fanapt, Rexulti, and Vraylar. The committee requested state data regarding the cost-impact of step therapy and requested that haloperidol be included as an option for step therapy. Additionally, the committee asked for data updates concerning polypharmacy prescribing in children and information on whether existing policies have successfully reduced prescriber burden.